Quantum Genomics Société Anonyme (ALQGC.PA)
EUR 0.07
(0.0%)
EUR 0.07
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -3.17 Million EUR | 87.28% |
| 2022 | -24.93 Million EUR | -43.65% |
| 2021 | -17.35 Million EUR | -7.0% |
| 2020 | -16.22 Million EUR | -78.71% |
| 2019 | -9.07 Million EUR | 24.28% |
| 2018 | -11.99 Million EUR | -27.81% |
| 2017 | -9.38 Million EUR | -78.98% |
| 2016 | -5.24 Million EUR | -39.24% |
| 2015 | -3.76 Million EUR | -70.57% |
| 2014 | -2.2 Million EUR | -43.17% |
| 2013 | -1.54 Million EUR | -82.76% |
| 2012 | -843.39 Thousand EUR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -8.21 Million EUR | 0.0% |
| 2023 Q4 | -1.18 Million EUR | 0.0% |
| 2023 FY | -3.17 Million EUR | 87.28% |
| 2023 Q2 | -1.98 Million EUR | 0.0% |
| 2022 Q4 | -16.08 Million EUR | 0.0% |
| 2022 Q2 | -11.95 Million EUR | 0.0% |
| 2022 FY | -24.93 Million EUR | -43.65% |
| 2021 FY | -17.35 Million EUR | -7.0% |
| 2021 Q4 | -11.17 Million EUR | 0.0% |
| 2021 Q2 | -6.18 Million EUR | 0.0% |
| 2020 FY | -16.22 Million EUR | -78.71% |
| 2020 Q2 | -5.08 Million EUR | 0.0% |
| 2020 Q4 | -11.14 Million EUR | 0.0% |
| 2019 FY | -9.07 Million EUR | 24.28% |
| 2019 Q2 | -4.12 Million EUR | 0.0% |
| 2019 Q4 | -4.94 Million EUR | 0.0% |
| 2018 Q4 | -5.78 Million EUR | 0.0% |
| 2018 FY | -11.99 Million EUR | -27.81% |
| 2018 Q2 | -6.2 Million EUR | 0.0% |
| 2017 Q2 | -4.03 Million EUR | 0.0% |
| 2017 FY | -9.38 Million EUR | -78.98% |
| 2017 Q4 | -5.34 Million EUR | 0.0% |
| 2016 FY | -5.24 Million EUR | -39.24% |
| 2016 Q4 | -2.48 Million EUR | 0.0% |
| 2016 Q2 | -2.75 Million EUR | 0.0% |
| 2015 Q4 | -1.97 Million EUR | 0.0% |
| 2015 FY | -3.76 Million EUR | -70.57% |
| 2015 Q2 | -1.78 Million EUR | 0.0% |
| 2014 Q2 | -1.27 Million EUR | 0.0% |
| 2014 Q4 | -929.19 Thousand EUR | 0.0% |
| 2014 FY | -2.2 Million EUR | -43.17% |
| 2013 Q3 | -385.1 Thousand EUR | 46.93% |
| 2013 Q1 | -385.1 Thousand EUR | 0.0% |
| 2013 Q2 | -725.71 Thousand EUR | -88.45% |
| 2013 Q4 | -815.71 Thousand EUR | -111.82% |
| 2013 FY | -1.54 Million EUR | -82.76% |
| 2012 Q3 | -210.96 Thousand EUR | 0.0% |
| 2012 Q1 | -210.96 Thousand EUR | 0.0% |
| 2012 FY | -843.39 Thousand EUR | 0.0% |
| 2012 Q4 | -385.1 Thousand EUR | -82.54% |
| 2012 Q2 | -210.96 Thousand EUR | 0.0% |
| 2011 Q4 | -210.96 Thousand EUR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| ABIONYX Pharma SA | -3.51 Million EUR | 9.865% |
| ABIVAX Société Anonyme | -147.74 Million EUR | 97.854% |
| Adocia SA | -21.16 Million EUR | 85.016% |
| Aelis Farma SA | -5.07 Million EUR | 37.555% |
| Biophytis S.A. | -17.02 Million EUR | 81.376% |
| Advicenne S.A. | -7.03 Million EUR | 54.9% |
| genOway Société anonyme | 1.56 Million EUR | 302.284% |
| IntegraGen SA | -171.39 Thousand EUR | -1750.038% |
| Medesis Pharma S.A. | -3.95 Million EUR | 19.915% |
| Neovacs S.A. | -8.74 Million EUR | 63.733% |
| NFL Biosciences SA | -3.74 Million EUR | 15.339% |
| Plant Advanced Technologies SA | 79.16 Thousand EUR | 4105.289% |
| Sensorion SA | -22.06 Million EUR | 85.628% |
| Theranexus Société Anonyme | -6.82 Million EUR | 53.559% |
| TME Pharma N.V. | -6.73 Million EUR | 52.925% |
| Valbiotis SA | -7.36 Million EUR | 56.963% |
| TheraVet SA | -1.57 Million EUR | -101.88% |
| Valerio Therapeutics Société anonyme | -20.34 Million EUR | 84.413% |
| DBV Technologies S.A. | -67.26 Million EUR | 95.286% |
| Genfit S.A. | -28.89 Million EUR | 89.026% |
| GeNeuro SA | -14.75 Million EUR | 78.512% |
| Innate Pharma S.A. | -7.57 Million EUR | 58.112% |
| Inventiva S.A. | -110.42 Million EUR | 97.128% |
| MaaT Pharma SA | -19.71 Million EUR | 83.918% |
| MedinCell S.A. | -25.03 Million EUR | 87.335% |
| Nanobiotix S.A. | -39.7 Million EUR | 92.013% |
| OSE Immunotherapeutics SA | -23 Million EUR | 86.215% |
| Poxel S.A. | -35.09 Million EUR | 90.963% |
| GenSight Biologics S.A. | -26.22 Million EUR | 87.906% |
| Transgene SA | -22.32 Million EUR | 85.798% |
| Valneva SE | -101.42 Million EUR | 96.874% |